Insider Transactions in Q3 2021 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2021
|
John Maraganore Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,979
-2.83%
|
$6,761,821
$199.85 P/Share
|
|
Aug 13
2021
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,979
+12.02%
|
$237,853
$7.1 P/Share
|
|
Aug 09
2021
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
10,834
-49.14%
|
$2,166,800
$200.0 P/Share
|
|
Aug 09
2021
|
Akshay Vaishnaw President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,834
+32.95%
|
$682,542
$63.0 P/Share
|
|
Aug 06
2021
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
53,064
-82.8%
|
$10,559,736
$199.0 P/Share
|
|
Aug 06
2021
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
53,064
+34.93%
|
$4,085,928
$77.1 P/Share
|
|
Aug 05
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-66.09%
|
$1,880,000
$188.95 P/Share
|
|
Aug 05
2021
|
Laurie Keating EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.01%
|
$880,000
$88.95 P/Share
|
|
Jul 12
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,812
-32.26%
|
$1,212,536
$178.97 P/Share
|
|
Jul 12
2021
|
Laurie Keating EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,812
+25.1%
|
$585,832
$86.97 P/Share
|